Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Work In Process (2020 - 2022)

Rapid Micro Biosystems' Work In Process history spans 3 years, with the latest figure at $722000.0 for Q2 2022.

  • On a quarterly basis, Work In Process changed 0.28% to $722000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $722000.0, a 0.28% change, with the full-year FY2021 number at $1.2 million, up 3.78% from a year prior.
  • Work In Process hit $722000.0 in Q2 2022 for Rapid Micro Biosystems, down from $873000.0 in the prior quarter.
  • Over the last five years, Work In Process for RPID hit a ceiling of $1.2 million in Q4 2021 and a floor of $689000.0 in Q3 2021.
  • Historically, Work In Process has averaged $904833.3 across 3 years, with a median of $797500.0 in 2022.
  • Biggest five-year swings in Work In Process: increased 3.78% in 2021 and later grew 0.28% in 2022.
  • Tracing RPID's Work In Process over 3 years: stood at $1.2 million in 2020, then increased by 3.78% to $1.2 million in 2021, then crashed by 41.54% to $722000.0 in 2022.
  • Business Quant data shows Work In Process for RPID at $722000.0 in Q2 2022, $873000.0 in Q1 2022, and $1.2 million in Q4 2021.